HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast.
about
Zoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cellsMultiplexing spheroid volume, resazurin and acid phosphatase viability assays for high-throughput screening of tumour spheroids and stem cell neurospheresGeneration of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug TestingChemotaxis-driven assembly of endothelial barrier in a tumor-on-a-chip platform.Direct visualization of the phenotype of hypoxic tumor cells at single cell resolution in vivo using a new hypoxia probe.Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast.Jagged1 modulated tumor-associated macrophage differentiation predicts poor prognosis in patients with invasive micropapillary carcinoma of the breast.PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy.A strategy for integrating essential three-dimensional microphysiological systems of human organs for realistic anticancer drug screening.The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors.Down-regulation of hypoxia-inducible factor-1 suppresses malignant biological behavior of triple-negative breast cancer cells.Combining antiangiogenic therapy with adoptive cell immunotherapy exerts better antitumor effects in non-small cell lung cancer modelsIntratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expressionZoledronic acid overcomes chemoresistance and immunosuppression of malignant mesotheliomaTargeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer modelAnterior gradient 2 is a binding stabilizer of hypoxia inducible factor-1α that enhances CoCl2 -induced doxorubicin resistance in breast cancer cells.Inhibition of Lysyl Oxidases Improves Drug Diffusion and Increases Efficacy of Cytotoxic Treatment in 3D Tumor ModelsIdentification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1Activation of AMP-Activated Protein Kinase α and Extracelluar Signal-Regulated Kinase Mediates CB-PIC-Induced Apoptosis in Hypoxic SW620 Colorectal Cancer CellsCross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses.Silencing HIF-1α reduces the adhesion and secretion functions of acute leukemia hBMSCs.The synthetic peptide CIGB-300 modulates CK2-dependent signaling pathways affecting the survival and chemoresistance of non-small cell lung cancer cell linesHistone deacetylase 2 regulates doxorubicin (Dox) sensitivity of colorectal cancer cells by targeting ABCB1 transcription.E-cadherin increasing multidrug resistance protein 1 via hypoxia-inducible factor-1α contributes to multicellular resistance in colorectal cancer.AEG-1 is associated with hypoxia-induced hepatocellular carcinoma chemoresistance via regulating PI3K/AKT/HIF-1alpha/MDR-1 pathway.Triptolide, a Chinese herbal extract, enhances drug sensitivity of resistant myeloid leukemia cell lines through downregulation of HIF-1α and Nrf2.The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance.Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha.Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells.Inhibition of Hypoxia Inducible Factor Alpha and Astrocyte-Elevated Gene-1 Mediates Cryptotanshinone Exerted Antitumor Activity in Hypoxic PC-3 Cells.Expression of multidrug resistance protein P-glycoprotein in correlation with markers of hypoxia (HIF-1α, EPO, EPO-R) in invasive breast cancer with metastasis to lymph nodes.Relationship between morphological and cytogenetic heterogeneity in invasive micropapillary carcinoma of the breast: a report of one case.Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance.Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models.Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning.Tumor stressors induce two mechanisms of intracellular p-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones.Hyperglycemia Promotes Chemoresistance Through the Reduction of the Mitochondrial DNA Damage, the Bax/Bcl-2 and Bax/Bcl-XL Ratio, and the Cells in Sub-G1 Phase Due to Antitumoral Drugs Induced-Cytotoxicity in Human Colon Adenocarcinoma Cells
P2860
Q28486174-5F4394DF-0AC3-4CD7-BC17-E52946D24FEBQ28541848-2CFD5C48-57CE-451B-84C9-E2B33741E3A9Q28548481-745DBDA1-7F76-4CDC-9A9E-64FDF685B646Q30755664-FE6D9B16-8504-456A-A49F-C63A5F27B861Q30826469-984DB621-4F40-44CD-B5AE-5C3CC7D79107Q33579776-463F9819-B57F-409D-9DDB-8E0433EE2364Q33606232-6B8A0360-E17C-4CBF-923A-232E29E37F16Q33667531-99E86228-DB8C-4B40-83EF-28617D7E57B6Q34143251-25FB9AD4-96CE-48AE-9F50-56D10303E37AQ34615075-430FF1BA-B52F-4BB1-AA63-6018CF345477Q34769786-46642375-A0A6-4DED-AED5-A035D63B8725Q34782683-4CB26CAA-986A-445E-953D-BEE87CBEEF66Q35149179-77952799-1713-427C-8741-D1231DC70F61Q35176037-ED521768-0AFA-459B-9826-1486E47BD550Q35605388-263CA367-A819-4C21-A35D-D0A736DD357DQ36016235-2E5D84A5-3054-4D33-B0E1-CF03B156FFA3Q36334121-4539B808-E963-4C2D-8F58-8BD67DCD5D43Q36717999-69AA464C-63A0-4A6E-BDDB-7EBCDCAC5861Q36755014-84BD29E7-DBB9-48FD-AFC5-07191C0E8134Q37351778-8FC04772-2D34-48AE-B89E-7C84A6E9A8BBQ37370837-DD3180B4-CF85-47A8-950B-8FE8C4B0513DQ38709045-697EA6E5-C421-472E-A5AB-DD194D5A852BQ38796545-2274D567-EA4A-44B4-8659-DC26FB5AEED9Q38848488-0194CDFC-5476-4774-AE13-A702C2EE4FD1Q38880782-1647D90B-FD97-4D1C-B4DB-0D36015D1C08Q39113045-A870A8FA-777B-430E-BE3C-37EC8E23CBEDQ39682085-9B234199-07BE-4839-ADB3-57E30114C654Q41347745-8624A763-0226-4C71-8066-CEDA871E3A5AQ42118943-A9726C06-B7B5-477E-B41B-0E23DA8D8127Q42406107-90D1D655-AB59-4DDB-A85B-E3971C810D7EQ47140172-602D88CD-1EED-46BD-B6DC-6891AC1681BDQ48172709-10BAE863-C442-463D-BF23-B9BF44F32C29Q48809877-BD1D5189-C855-40F1-A9F2-2BBC35AB0609Q49197891-0957D41F-9405-4A8D-B78E-A15009EEF221Q49283462-36BC3002-57A7-4ECE-96C5-8C7C48F915B4Q50158298-DDD9897D-AE0F-4B45-B0B5-FF1BD8C0159FQ58785748-E8F1BCDA-1F72-4520-AC5D-82BE246EBD1C
P2860
HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
HIF-1 activation induces doxor ...... llary carcinoma of the breast.
@ast
HIF-1 activation induces doxor ...... llary carcinoma of the breast.
@en
HIF-1 activation induces doxor ...... llary carcinoma of the breast.
@nl
type
label
HIF-1 activation induces doxor ...... llary carcinoma of the breast.
@ast
HIF-1 activation induces doxor ...... llary carcinoma of the breast.
@en
HIF-1 activation induces doxor ...... llary carcinoma of the breast.
@nl
prefLabel
HIF-1 activation induces doxor ...... llary carcinoma of the breast.
@ast
HIF-1 activation induces doxor ...... llary carcinoma of the breast.
@en
HIF-1 activation induces doxor ...... llary carcinoma of the breast.
@nl
P2093
P2860
P50
P356
P1433
P1476
HIF-1 activation induces doxor ...... illary carcinoma of the breast
@en
P2093
Amalia Bosia
Dimas C Belisario
Elena Allia
Manuela Polimeni
Sophie Doublier
P2860
P2888
P356
10.1186/1471-2407-12-4
P407
P577
2012-01-04T00:00:00Z
P5875
P6179
1005113443